110
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Glial Fibrillary Acidic Protein as a Potential Indicator for Symptomatic Intracranial Hemorrhage in Acute Ischemic Patients Undergoing Endovascular Thrombectomy

, , , , , , & ORCID Icon show all
Pages 123-132 | Received 04 Nov 2023, Accepted 17 Jan 2024, Published online: 21 Jan 2024

References

  • Feigin VL, Stark BA, Johnson CO., GBD. Stroke collaborators. global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet Neurol. 2021; 20(10): 795–820. doi:10.1016/S1474-4422(21)00252-0
  • Ding C, Wu Y, Chen X, et al. Global, regional, and national burden and attributable risk factors of neurological disorders: the global burden of disease study 1990–2019. Front Public Health. 2022;10:952161. doi:10.3389/fpubh.2022.952161
  • Goyal M, Menon BK, van Zwam WH, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016;387(10029):1723–1731. doi:10.1016/S0140-6736(16)00163-X
  • Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American heart association/American stroke Association. Stroke. 2019;50(12): e344–e418. doi:10.1161/STR.0000000000000211
  • Hao Y, Yang D, Wang H, et al. Predictors for symptomatic intracranial hemorrhage after endovascular treatment of acute ischemic stroke. Stroke. 2017;48(5):1203–1209. doi:10.1161/STROKEAHA.116.016368
  • Tian B, Tian X, Shi Z, et al. Clinical and imaging indicators of hemorrhagic transformation in acute ischemic stroke after endovascular thrombectomy. Stroke. 2022;53(5):1674–1681. doi:10.1161/STROKEAHA.121.035425
  • van der Steen W, van der Ende NAM, Luijten SPR, et al. Type of intracranial hemorrhage after endovascular stroke treatment: association with functional outcome. J Neurointerv Surg. 2023;15(10):971–976. doi:10.1136/jnis-2022-019474
  • Kang Z, Wu L, Sun D, et al. Proximal hyperdense middle cerebral artery sign is associated with increased risk of asymptomatic hemorrhagic transformation after endovascular thrombectomy: a multicenter retrospective study. J Neurol. 2023;270(3):1587–1599. doi:10.1007/s00415-022-11500-5
  • Shi K, Tian DC, Li ZG, Ducruet AF, Lawton MT, Shi FD. Global brain inflammation in stroke. Lancet Neurol. 2019;18(11):1058–1066. doi:10.1016/s1474-4422(19)30078-x
  • van Bodegraven EJ, van Asperen JV, Robe PAJ, Hol EM. Importance of GFAP isoform-specific analyses in astrocytoma. Glia. 2019;67(8):1417–1433. doi:10.1002/glia.23594
  • Abdelhak A, Foschi M, Abu-Rumeileh S, et al. Blood GFAP as an emerging biomarker in brain and spinal cord disorders. Nat Rev Neurol. 2022;18(3):158–172. doi:10.1038/s41582-021-00616-3
  • Shen XN, Huang SY, Cui M, et al. Plasma glial fibrillary acidic protein in the Alzheimer disease continuum: relationship to other biomarkers, differential diagnosis, and prediction of clinical progression. Clin Chem. 2023;69(4):411–421. doi:10.1093/clinchem/hvad018
  • Ayrignac X, Le Bars E, Duflos C, et al. Serum GFAP in multiple sclerosis: correlation with disease type and MRI markers of disease severity. Sci Rep. 2020;10(1):10923. doi:10.1038/s41598-020-67934-2
  • Benussi A, Ashton NJ, Karikari TK, et al. Serum Glial Fibrillary Acidic Protein (GFAP) is a marker of disease severity in frontotemporal lobar degeneration. J Alzheimers Dis. 2020;77(3):1129–1141. doi:10.3233/jad-200608
  • Foerch C, Niessner M, Back T, et al. Diagnostic accuracy of plasma glial fibrillary acidic protein for differentiating intracerebral hemorrhage and cerebral ischemia in patients with symptoms of acute stroke. Clin Chem. 2012;58(1):237–245. doi:10.1373/clinchem.2011.172676
  • Katsanos AH, Makris K, Stefani D, et al. Plasma glial fibrillary acidic protein in the differential diagnosis of intracerebral hemorrhage. Stroke. 2017;48(9):2586–2588. doi:10.1161/STROKEAHA.117.018409
  • Pujol-Calderon F, Zetterberg H, Portelius E, et al. Prediction of outcome after endovascular embolectomy in anterior circulation stroke using biomarkers. Transl Stroke Res. 2022;13(1):65–76. doi:10.1007/s12975-021-00905-5
  • Chen CH, Chu HJ, Hwang YT, et al. Plasma neurofilament light chain level predicts outcomes in stroke patients receiving endovascular thrombectomy. J Neuroinflammation. 2021;18(1):195. doi:10.1186/s12974-021-02254-4
  • Shi G, Li M, Zhou R, et al. Procalcitonin related to stroke-associated pneumonia and clinical outcomes of acute ischemic stroke after IV rt-PA treatment. Cell Mol Neurobiol. 2022;42(5):1419–1427. doi:10.1007/s10571-020-01031-w
  • Shi G, Ke D, Gong P, et al. Serum YKL-40 levels and white matter hyperintensities in patients with acute ischemic stroke. J Inflamm Res. 2023;16:311–319. doi:10.2147/JIR.S398701
  • Adams HP, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. trial of org 10172 in acute stroke treatment. Stroke. 1993;24(1):35–41. doi:10.1161/01.str.24.1.35
  • Higashida RT, Furlan AJ. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke. 2003;34(8): e109–37. doi:10.1161/01.STR.0000082721.62796.09
  • Zaidat OO, Yoo AJ, Khatri P, et al. Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke. 2013;44(9):2650–2663. doi:10.1161/STROKEAHA.113.001972
  • von Kummer R, Broderick JP, Campbell BC, et al. The Heidelberg bleeding classification: classification of bleeding events after ischemic stroke and reperfusion therapy. Stroke. 2015;46(10):2981–2986. doi:10.1161/STROKEAHA.115.010049
  • Zhang X, Xie Y, Wang H, et al. Symptomatic intracranial hemorrhage after mechanical thrombectomy in Chinese ischemic stroke patients: the ASIAN score. Stroke. 2020;51(9):2690–2696. doi:10.1161/STROKEAHA.120.030173
  • Pencina MJ, D’Agostino RB, D’Agostino RB, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27(2):157–172. doi:10.1002/sim.2929
  • Alba AC, Agoritsas T, Walsh M, et al. Discrimination and calibration of clinical prediction models: users’ guides to the medical literature. JAMA. 2017;318(14):1377–1384. doi:10.1001/jama.2017.12126
  • Ospel JM, Qiu W, Menon BK, et al. Radiologic patterns of intracranial hemorrhage and clinical outcome after endovascular treatment in acute ischemic stroke: results from the ESCAPE-NA1 trial. Radiology. 2021;300(2):402–409. doi:10.1148/radiol.2021204560
  • Mohamed A, Shuaib A, Saqqur M, Fatima N. The impact of leptomeningeal collaterals in acute ischemic stroke: a systematic review and meta-analysis. Neurol Sci. 2023;44(2):471–489. doi:10.1007/s10072-022-06437-6
  • van der Steen W, van der Ende NAM, van Kranendonk KR, et al. Determinants of symptomatic intracranial hemorrhage after endovascular stroke treatment: a retrospective cohort study. Stroke. 2022;53(9):2818–2827. doi:10.1161/STROKEAHA.121.036195
  • Venditti L, Chassin O, Ancelet C, et al. Pre-procedural predictive factors of symptomatic intracranial hemorrhage after thrombectomy in stroke. J Neurol. 2021;268(5):1867–1875. doi:10.1007/s00415-020-10364-x
  • Heimfarth L, Passos FRS, Monteiro BS, Araujo AAS, Quintans Junior LJ, Quintans JSS. Serum glial fibrillary acidic protein is a body fluid biomarker: a valuable prognostic for neurological disease - A systematic review. Int Immunopharmacol. 2022;107:108624. doi:10.1016/j.intimp.2022.108624
  • Chen Y, Zhou S, Yang S, et al. Developing and predicting of early mortality after endovascular thrombectomy in patients with acute ischemic stroke. Front Neurosci. 2022;16:1034472. doi:10.3389/fnins.2022.1034472
  • Kam W, Holmes DN, Hernandez AF, et al. Association of recent use of non-vitamin k antagonist oral anticoagulants with intracranial hemorrhage among patients with acute ischemic stroke treated with alteplase. JAMA. 2022;327(8):760–771. doi:10.1001/jama.2022.0948
  • Yi T, Zhang Y, Chen WH, et al. Impact of leukoaraiosis in patients with acute ischemic stroke treated with thrombectomy: a post hoc analysis of the DIRECT-MT trial. J Neurointerv Surg. 2023;15(2):139–145. doi:10.1136/neurintsurg-2021-018293
  • Choi KH, Kim JH, Kang KW, et al. Impact of microbleeds on outcome following recanalization in patients with acute ischemic stroke. Stroke. 2019;50(1):127–134. doi:10.1161/STROKEAHA.118.023084
  • Liu D, Nie X, Pan Y, et al. Adverse outcomes associated with higher mean blood pressure and greater blood pressure variability immediately after successful embolectomy in those with acute ischemic stroke, and the influence of pretreatment collateral circulation status. J Am Heart Assoc. 2021;10(5): e019350. doi:10.1161/JAHA.120.019350
  • Chen Y, Nguyen TN, Mofatteh M, et al. Association of early increase in body temperature with symptomatic intracranial hemorrhage and unfavorable outcome following endovascular therapy in patients with large vessel occlusion stroke. J Integr Neurosci. 2022;21(6):156. doi:10.31083/j.jin2106156